Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.


Journal

Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624

Informations de publication

Date de publication:
21 05 2019
Historique:
received: 13 03 2019
accepted: 01 05 2019
entrez: 22 5 2019
pubmed: 22 5 2019
medline: 11 6 2020
Statut: epublish

Résumé

Syringe services programs (SSPs) are evidence-based interventions that are associated with decreases in prevalence and incidence rates of HIV and viral hepatitis among people who inject drugs (PWID). SSPs are also effective conduits to deliver overdose prevention resources among PWID. In December 2015, the Kanawha-Charleston Health Department (KCHD) in West Virginia implemented a SSP; however, the program was indefinitely suspended in early 2018 following policy changes that would have forced the program to operate in ways that conflicted with established best practices. The purpose of this research is to explore the public health implications of the suspension of the KCHD SSP among rural PWID. We conducted semi-structured interviews with 27 PWID (59.3% male, 88.9% White) to explore access to sterile injection equipment and overdose prevention resources, high-risk injection practices, and HIV risk perceptions following the KCHD SSP suspension. Participants were recruited from street locations frequented by PWID. Interviews were audio-recorded and transcribed verbatim. We employed an iterative, modified constant comparison approach to systematically code and synthesize textual interview data. Participants described the KCHD SSP as providing a variety of harm reduction services to PWID and being able to speak honestly with SSP staff about their drug use without fear of stigmatization. The suspension of the KCHD SSP fundamentally changed the public health landscape for PWID, ushering in a new era of increased risks for acquiring bloodborne infections and overdose. PWID described more frequently injecting with used syringes and engaging in a range of high-risk injection practices after the SSP was suspended. PWID also discussed having decreased access to naloxone and being less likely to get routinely tested for HIV following the KCHD SSP suspension. This research demonstrates that the suspension of a SSP in rural West Virginia increased risks for HIV/HCV acquisition and overdose among PWID. The suspension of the SSP led to community-wide decreases in access to sterile injection equipment and naloxone among PWID. The suspension of the KCHD SSP should be viewed as a call to action for sustaining evidence-based interventions in the face of sociopolitical forces that attempt to subvert public health.

Sections du résumé

BACKGROUND
Syringe services programs (SSPs) are evidence-based interventions that are associated with decreases in prevalence and incidence rates of HIV and viral hepatitis among people who inject drugs (PWID). SSPs are also effective conduits to deliver overdose prevention resources among PWID. In December 2015, the Kanawha-Charleston Health Department (KCHD) in West Virginia implemented a SSP; however, the program was indefinitely suspended in early 2018 following policy changes that would have forced the program to operate in ways that conflicted with established best practices. The purpose of this research is to explore the public health implications of the suspension of the KCHD SSP among rural PWID.
METHODS
We conducted semi-structured interviews with 27 PWID (59.3% male, 88.9% White) to explore access to sterile injection equipment and overdose prevention resources, high-risk injection practices, and HIV risk perceptions following the KCHD SSP suspension. Participants were recruited from street locations frequented by PWID. Interviews were audio-recorded and transcribed verbatim. We employed an iterative, modified constant comparison approach to systematically code and synthesize textual interview data.
RESULTS
Participants described the KCHD SSP as providing a variety of harm reduction services to PWID and being able to speak honestly with SSP staff about their drug use without fear of stigmatization. The suspension of the KCHD SSP fundamentally changed the public health landscape for PWID, ushering in a new era of increased risks for acquiring bloodborne infections and overdose. PWID described more frequently injecting with used syringes and engaging in a range of high-risk injection practices after the SSP was suspended. PWID also discussed having decreased access to naloxone and being less likely to get routinely tested for HIV following the KCHD SSP suspension.
CONCLUSIONS
This research demonstrates that the suspension of a SSP in rural West Virginia increased risks for HIV/HCV acquisition and overdose among PWID. The suspension of the SSP led to community-wide decreases in access to sterile injection equipment and naloxone among PWID. The suspension of the KCHD SSP should be viewed as a call to action for sustaining evidence-based interventions in the face of sociopolitical forces that attempt to subvert public health.

Identifiants

pubmed: 31109339
doi: 10.1186/s12954-019-0305-7
pii: 10.1186/s12954-019-0305-7
pmc: PMC6528286
doi:

Substances chimiques

Narcotic Antagonists 0
Naloxone 36B82AMQ7N
Methamphetamine 44RAL3456C

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Subventions

Organisme : NIDA NIH HHS
ID : K01 DA046234
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI087714
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI117970
Pays : United States

Références

AIDS Behav. 2016 Jan;20(1):22-8
pubmed: 26336945
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):175-6
pubmed: 7552482
Harm Reduct J. 2017 May 17;14(1):25
pubmed: 28514954
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S133-8
pubmed: 9663636
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
AIDS Behav. 2014 Nov;18(11):2144-55
pubmed: 24824043
Lancet. 1997 Jun 21;349(9068):1797-800
pubmed: 9269214
Am J Public Health. 1999 Jan;89(1):43-6
pubmed: 9987463
Int J Drug Policy. 2015 Jul;26(7):688-95
pubmed: 25979789
AIDS Care. 2005 Jul;17(5):558-65
pubmed: 16036242
Lancet. 1996 Oct 12;348(9033):987-91
pubmed: 8855855
MMWR Morb Mortal Wkly Rep. 2015 Dec 11;64(48):1337-41
pubmed: 26655918
Am J Public Health. 2002 Apr;92(4):655-9
pubmed: 11919067
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 15;16(5):400-6
pubmed: 9420320
AIDS. 2000 Mar 31;14(5):605-11
pubmed: 10780722
J Rural Health. 2004 Summer;20(3):206-9
pubmed: 15298094
AIDS Care. 2011 May;23(5):638-45
pubmed: 21293995
N Engl J Med. 2016 Jul 21;375(3):229-39
pubmed: 27468059
Soc Work Public Health. 2015;30(4):385-96
pubmed: 25950907
MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):453-8
pubmed: 25950251
NCHS Data Brief. 2018 Nov;(329):1-8
pubmed: 30500323
MMWR Morb Mortal Wkly Rep. 2015 May 1;64(16):443-4
pubmed: 25928470
Am J Public Health. 1995 Nov;85(11):1531-7
pubmed: 7485666
AIDS. 1989 May;3(5):267-72
pubmed: 2504230
J Psychoactive Drugs. 2008 Jun;40(2):121-9
pubmed: 18720660
Lancet HIV. 2018 Oct;5(10):e569-e577
pubmed: 30220531
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):323-331
pubmed: 27763996
AIDS. 1995 Jun;9(6):611-7
pubmed: 7662201
Am J Public Health. 2019 Mar;109(3):445-450
pubmed: 30676803

Auteurs

Sean T Allen (ST)

Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA. sallen63@jhu.edu.

Suzanne M Grieb (SM)

Center for Child and Community Health Research, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, 21224, USA.

Allison O'Rourke (A)

DC Center for AIDS Research, Department of Psychology, George Washington University, 2125 G St. NW, Washington, DC, 20052, USA.

Ryan Yoder (R)

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA.

Elise Planchet (E)

Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA.

Rebecca Hamilton White (RH)

Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA.

Susan G Sherman (SG)

Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH